Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Responsive Gel Promotes Bone Growth on Implants

By HospiMedica International staff writers
Posted on 09 Apr 2014
An innovative gel can be used to coat titanium implant surfaces and bind protein molecules that promote bone formation. More...


Researchers at Uppsala University (Sweden) and Institut Laue-Langevin (Grenoble, France) succeeded in binding bone morphogenetic protein 2 (BMP-2) to hyaluronic acid—an anionic, nonsulfated glycosaminoglycan that is one of the chief components of the extracellular matrix (ECM)—with covalently linked bisphosphonate (BP) ligands. The result was a stable hydrogel that they used to coat titanium implants. They also demonstrated that the layer of BMP-2 was stable in water, but could be released slowly by adding solutions that contain calcium ions.

The gel layers, a few millionths of a millimeter thick, were characterized using neutron reflection at the ILL, a technique that provides a detailed picture of what happens at a surface and to track the amount of protein present. The researchers have also launched in-vivo trials in collaboration with the Swedish Agricultural University (SLU; Uppsala, Sweden) of similar materials for metal implants in rabbits. The ongoing studies will provide a step towards transfer of the results to clinical applications. The study was published early online on March 31, 2014, in Advanced Engineering Materials.

“We envisage that the materials will be used in medicine to modulate the healing process in bone,” said Associate Professor Dmitri Ossipov, PhD, of the Uppsala department of medicinal chemistry. “Neutrons are an ideal tool to understand the interactions of metal surfaces, polysaccharide biopolymers, and proteins thanks to a contrast matching technique that highlights only the protein components at the interface.”

“Neutron scattering techniques are increasingly relevant to optimize bio-materials and to study systems that relate to health,” said Giovanna Fragneto, PhD, of the ILL. “The importance of combining conventional laboratory studies with those at a large scale facility to give a complete picture of a process was proven once more.”

Related Links:

Uppsala University
Institut Laue-Langevin
Swedish Agricultural University



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.